摘要
目的:观察分析血管紧张素转化酶抑制剂(ACEI)联合β受体阻滞剂治疗慢型克山病临床效果。方法:2008年在内蒙古克山病病区选择一定数量的慢型克山病患者为治疗对象,以ACEI联合β受体阻滞剂以及利尿剂为治疗组用药,以ACEI联合强心药以及利尿剂为对照组用药,进行为期6个月的药物治疗,以治疗初期、末期心电图诊断结果、心胸比例结果、心功能分级结果、克山病类型、劳动能力为判定指标,以其中一项指标改善即为治疗有效,统计两组的有效人数及有效率。结果:71人参与治疗组用药,60人有效,有效率85%,65人参与对照组用药,43人有效,有效率为66%,两组有效率有显著性差异,治疗组高于对照组,x^2=6.22,P<0.05。结论:血管紧张素转化酶抑制剂联合β受体阻滞剂治疗以充血性心力衰竭为主要特征的慢型克山病效果明显,对改善患者健康状况有意义。
Objective:To observe and analyze the curative effect of chronic Keshan Disease treated by ACEI and Beta Blockers.Methods:Certain amounts of chronic KD patients in KD area have been chosen and treated by ACEI and Beta Blockers for six months.A controlled group was treated by cardiotonic medicine.The electrocardiogram description,the proportion of heart and chest,the classification of heart function,the type of KD and labour capacity at the initial and last stage of the treatment are taken as the deciding indexes.If one of the indexes has been improved then the treatment will be regarded effective.The effective number and efficiency have been counted.Results:71 patients were involved in ACEI Group,60 of which have been cured.The Curative Effect of ACEI group is 85%.While 65 patients were in Cardiotonic Group,and 43 of them have been cured.The curative effect of cardiotonic medicine Group is 66%.The curative effect of ACEI group is higher than cardiotonic group,x^2 = 6.22,P< 0.05.Conclusion:The curative effect of chronic Keshan Disease treated by ACEI and Beta Blockers is of great significance in improving the healthy condition of KD patients.
出处
《内蒙古医学杂志》
2010年第S5期4-6,共3页
Inner Mongolia Medical Journal
